Tomáš Freiberger
Masaryk University
186 Papers
476 Citations
Tomáš Freiberger is an academic researcher from Masaryk University. The author has contributed to research in topics: Medicine & Familial hypercholesterolemia. The author has an hindex of 27, co-authored 165 publications. Previous affiliations of Tomáš Freiberger include Central European Institute of Technology & First Faculty of Medicine, Charles University in Prague.
Chat about Author
Papers
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Oliver A. Cornely,S. Arikan-Akdagli,Eric Dannaoui,Andreas H. Groll,Katrien Lagrou,Arunaloke Chakrabarti,Fanny Lanternier,Fanny Lanternier,Livio Pagano,Anna Skiada,Murat Akova,Maiken Cavling Arendrup,Teun Boekhout,Teun Boekhout,Anuradha Chowdhary,Manuel Cuenca-Estrella,Tomáš Freiberger,Jesús Guinea,Josep Guarro,S. de Hoog,William W. Hope,Elizabeth M. Johnson,Shallu Kathuria,Michaela Lackner,Cornelia Lass-Flörl,O. Lortholary,Jacques F. Meis,Joseph Meletiadis,Patricia Muñoz,Malcolm Richardson,Emmanuel Roilides,Anna Maria Tortorano,Andrew J. Ullmann,A.D. van Diepeningen,Paul E. Verweij,George Petrikkos +35 more
TL;DR: These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis and strongly recommend continuing treatment until complete response demonstrated on imaging and permanent reversal of predisposing factors.
846
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
Amy C. Sturm,Joshua W. Knowles,Samuel S. Gidding,Zahid Ahmad,Catherine D. Ahmed,Christie M. Ballantyne,Seth J. Baum,Mafalda Bourbon,Alain Carrié,Marina Cuchel,Sarah D. de Ferranti,Joep C. Defesche,Tomáš Freiberger,Ray E. Hershberger,G. Kees Hovingh,Lala Karayan,Johannes Jacob Pieter Kastelein,Iris Kindt,Stacey R. Lane,Sarah Leigh,MacRae F. Linton,Pedro Mata,William A. Neal,Børge G. Nordestgaard,Raul D. Santos,Mariko Harada-Shiba,Eric J.G. Sijbrands,Nathan O. Stitziel,Shizuya Yamashita,Katherine Wilemon,David H. Ledbetter,Daniel J. Rader +31 more
TL;DR: The Expert Consensus Panel recommends that FH genetic testing become the standard of care for patients with definite or probable FH, as well as for their at-risk relatives, and more accurate risk stratification.
502
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Anna Maria Tortorano,Malcolm Richardson,Emmanuel Roilides,A.D. van Diepeningen,Morena Caira,Patricia Muñoz,Elizabeth M. Johnson,Joseph Meletiadis,Zoi Dorothea Pana,Michaela Lackner,Paul E. Verweij,Tomáš Freiberger,Oliver A. Cornely,S. Arikan-Akdagli,Eric Dannaoui,Andreas H. Groll,Katrien Lagrou,Arunaloke Chakrabarti,Fanny Lanternier,Fanny Lanternier,Livio Pagano,Anna Skiada,Murat Akova,Maiken Cavling Arendrup,Teun Boekhout,Teun Boekhout,Anuradha Chowdhary,Manuel Cuenca-Estrella,Jesús Guinea,Josep Guarro,S. de Hoog,William W. Hope,Shallu Kathuria,O. Lortholary,O. Lortholary,Jacques F. Meis,Andrew J. Ullmann,George Petrikkos,Cornelia Lass-Flörl +38 more
TL;DR: Mycoses summarized in the hyalohyphomycosis group are heterogeneous, defined by the presence of hyaline (non-dematiaceous) hyphae, and management usually consists of surgery and antifungal treatment, depending on the clinical presentation.
477
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D. Santos,Samuel S. Gidding,Robert A. Hegele,Marina Cuchel,Philip J. Barter,Gerald F. Watts,Seth J. Baum,Alberico L. Catapano,M. John Chapman,Joep C. Defesche,Emanuela Folco,Tomáš Freiberger,Jacques Genest,G. Kees Hovingh,Mariko Harada-Shiba,Steve E. Humphries,Ann S Jackson,Pedro Mata,Patrick M. Moriarty,Frederick J. Raal,Khalid Al-Rasadi,Kausik K. Ray,Zelijko Reiner,Eric J.G. Sijbrands,Shizuya Yamashita +24 more
TL;DR: This Review aims to define a phenotype for severe familial hypercholesterolaemia and identify people at highest risk for cardiovascular disease, based on the concentration of LDL cholesterol in blood and individuals' responsiveness to conventional lipid-lowering treatment.
398
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects
Charlotte Schwab,Annemarie Gabrysch,Peter Olbrich,Virginia Patiño,Klaus Warnatz,Daniel Wolff,Akihiro Hoshino,Masao Kobayashi,Kohsuke Imai,Masatoshi Takagi,Ingunn Dybedal,Jamanda A. Haddock,David M. Sansom,José Manuel Lucena,Maximilian Seidl,Annette Schmitt-Graeff,Veronika Reiser,Florian Emmerich,Natalie Frede,Alla Bulashevska,Ulrich Salzer,Desirée Schubert,Seiichi Hayakawa,Satoshi Okada,Maria Kanariou,Zeynep Yesim Kucuk,Hugo Chapdelaine,Lenka Petruzelkova,Zdenek Sumnik,Anna Sediva,Mary Slatter,Peter D. Arkwright,Andrew J. Cant,Hanns-Martin Lorenz,Thomas Giese,Vassilios Lougaris,Alessandro Plebani,Christina Price,Kathleen E. Sullivan,Michel Moutschen,Jiri Litzman,Tomáš Freiberger,Frank L. van de Veerdonk,Mike Recher,Michael H. Albert,Fabian Hauck,Suranjith L. Seneviratne,Jana Pachlopnik Schmid,Antonios G.A. Kolios,Gary Unglik,Christian Klemann,Christian Klemann,Carsten Speckmann,Stephan Ehl,Alan M. Leichtner,Richard S. Blumberg,Andre Franke,Scott B. Snapper,Sebastian Zeissig,Sebastian Zeissig,Sebastian Zeissig,Charlotte Cunningham-Rundles,Lisa Giulino-Roth,Olivier Elemento,Gregor Dückers,Tim Niehues,Eva Fronkova,Veronika Kanderova,Craig D. Platt,Janet Chou,Talal A. Chatila,Raif S. Geha,Elizabeth M. McDermott,Su Bunn,Monika Kurzai,Ansgar Schulz,Laia Alsina,Ferran Casals,Angela Deyà-Martínez,Sophie Hambleton,Hirokazu Kanegane,Kjetil Taskén,Olaf Neth,Bodo Grimbacher,Bodo Grimbacher +84 more
TL;DR: The penetrance, clinical features, laboratory values, and outcomes of treatment options were assessed in a worldwide cohort of CTLA4 mutation carriers, finding affected mutation carriers with CTLA‐4 insufficiency can present in any medical specialty.